PRNewswire

TAIPEI and SAN DIEGO, Oct. 14, 2024 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that FDA issues Study May Proceed letter for its developing drug Pi

ABU DHABI, UAE, Oct. 14, 2024 /PRNewswire/ — TÜV Rheinland has launched an innovative certification program that qualifies materials for the emerging hydrogen economy. The “H2-Ready” Certification confirms that materials used in critical applications such as piping and pressure ve

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: